Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1420-9071
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants ; volume:79 ; number:4 ; day:16 ; month:3 ; year:2022 ; pages:1-20 ; date:4.2022
Cellular and molecular life sciences ; 79, Heft 4 (16.3.2022), 1-20, 4.2022
- Creator
-
Borgo, Christian
D’Amore, Claudio
Capurro, Valeria
Tomati, Valeria
Sondo, Elvira
Cresta, Federico
Castellani, Carlo
Pedemonte, Nicoletta
Salvi, Mauro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00018-022-04215-3
- URN
-
urn:nbn:de:101:1-2022070910080081353557
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borgo, Christian
- D’Amore, Claudio
- Capurro, Valeria
- Tomati, Valeria
- Sondo, Elvira
- Cresta, Federico
- Castellani, Carlo
- Pedemonte, Nicoletta
- Salvi, Mauro
- SpringerLink (Online service)
Other Objects (12)
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
UBE1L2, a novel E1 enzyme specific for ubiquitin
Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie
Zystische Fibrose : Ivacaftor ; Fallsammlung
Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment
A cascading activity-based probe sequentially targets E1–E2–E3 ubiquitin enzymes
From Purification to Drug Screening: CFTR TM3/4 Mutants as Models for Membrane Protein Misfolding in Disease
Regulation des CFTR
Regulation des CFTR
Mukoviszidose-Therapie: Lebensperspektive für Betroffene : Dreifachkombination Ivacaftor/Tezacaftor/Elexacaftor plus Ivacaftor im klinischen Alltag
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
UBE1L2, a novel E1 enzyme specific for ubiquitin
Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie
Zystische Fibrose : Ivacaftor ; Fallsammlung
Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment
A cascading activity-based probe sequentially targets E1–E2–E3 ubiquitin enzymes
From Purification to Drug Screening: CFTR TM3/4 Mutants as Models for Membrane Protein Misfolding in Disease
Regulation des CFTR
Regulation des CFTR
Mukoviszidose-Therapie: Lebensperspektive für Betroffene : Dreifachkombination Ivacaftor/Tezacaftor/Elexacaftor plus Ivacaftor im klinischen Alltag
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
UBE1L2, a novel E1 enzyme specific for ubiquitin
Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie
Zystische Fibrose : Ivacaftor ; Fallsammlung
Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment
A cascading activity-based probe sequentially targets E1–E2–E3 ubiquitin enzymes
From Purification to Drug Screening: CFTR TM3/4 Mutants as Models for Membrane Protein Misfolding in Disease
Regulation des CFTR
Regulation des CFTR